Hydralazine   body {font-family: 'Open Sans', sans-serif;} .ui-header .ui-title, .ui-footer .ui-title { margin-right: 0 !important; margin-left: 0 !important; } \* { margin:0px; padding:0px;} .ui-page { background: #f2f2f2 url(bg.jpg); line-height:1.5em;} #home\_link { color:#FFF; text-decoration:none; cursor:pointer; font-family:'AndikaBasicRegular',Arial, sans-serif; font-size:0.9em; margin-left:15%; } #home\_link span {font-size:0.6em;margin-left:15%; color: #D8D8D8; } h1 {font-family:'AndikaBasicRegular'; }

# Hydralazine

**Hydralazine (Apresoline)**  
**Class:** Antihypertensive, vasodilator  
Phthalazine derivative that activates guanylate cyclase to produce ARTERIOLAR relaxation.  
The antihypertensive drug of choice with a normal to low HR. Beta blockers are more preferred for HTN with a fast HR.  
**Doses:**  
**Hypertension:** 0.1-0.2mg/kg  
**Common Dose:** 10mg IVP  
**Peds:** 0.1-0.2mg/kg q4 hr  
**Effects:** Decrease BP and SVR  
Increases HR, CO and SV  
**Cause of increased HR:** Reflex baroreceptor-mediated increases in SNS activity due to a decrease in the SVR. The HR just increases to compensate for the arteriolar dilation.  
Vasodilator effects are more pronounced on the coronary, cerebral, renal, and splanchnic circulation.  
**Onset:** 10-20 minutes (be patient), don't get burned by redosing too soon!  
**Duration:** 3-6 hours  
**Adverse Reactions:**  
Reflex tachycardia and can invoke angina or myocardia ischemia.  
Lupis like syndrome in 10-20% for chronic therapy > 6 months.

#### Copyright Â© 2012